A Case of Hypereosinophilic Syndrome.

1991 ◽  
Vol 53 (3) ◽  
pp. 525-529 ◽  
Author(s):  
Kenichi MORI ◽  
Mamoru KOHDA ◽  
Yasuji MORI ◽  
Hiroaki UEKI ◽  
Masahiko KUMAGAI
2019 ◽  
Author(s):  
G Yavuz ◽  
T Kauke ◽  
OM Glück ◽  
T Weig ◽  
K Milger-Kneidinger ◽  
...  

1993 ◽  
Vol 29 (4) ◽  
pp. 757
Author(s):  
Gi Beom Kim ◽  
Ok Hwoa Kim ◽  
Jong Min Lee ◽  
Yeong Soon Sung ◽  
Duk Sik Kang

1997 ◽  
Vol 37 (4) ◽  
pp. 673 ◽  
Author(s):  
Kyung Sook Kim ◽  
Moon Gyu Lee ◽  
Young Chul Won ◽  
Eun Hye Lee ◽  
Han Na Noh ◽  
...  

1998 ◽  
Vol 60 (2) ◽  
pp. 134-136 ◽  
Author(s):  
Yuka TAKAMATSU ◽  
Tomomi SODO ◽  
Fumiaki SHIRASAKI ◽  
Hideaki SAKAI ◽  
Kazuhiko TAKEHARA ◽  
...  

2021 ◽  
Vol 2021 (1) ◽  
Author(s):  
Feihong Ding ◽  
Chaoping Wu ◽  
Yun Li ◽  
Sudipto Mukherjee ◽  
Subha Ghosh ◽  
...  

ABSTRACT Hypereosinophilia is defined as persistent eosinophilia (>1.5 × 109/L). Hypereosinophilic syndrome (HES) is a term used to describe a group of disorders characterized by sustained hypereosinophilia associated with end-organ damage. Based on underlying molecular mechanism of eosinophilia, there are different subtypes of HES. Diagnosis of HES subtype can be challenging, especially in the absence of overt lymphoid/myeloid neoplasms or discernable secondary causes. Long-term outpatient follow-up with periodic complete blood count and repeated bone marrow biopsy may be needed to monitor disease activity. Somatic signal transducer and activation transcription 5b (STAT5b) N642H mutation was recently found to be associated with myeloid neoplasms with eosinophilia. We report a case of HES who presented with pulmonary embolism and acute eosinophilic pneumonia, found to have recurrent STAT5b N642H mutation by next-generation sequencing, suggesting possible underlying myeloid neoplasm.


Sign in / Sign up

Export Citation Format

Share Document